S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
KH
INSIDER · SYRE · Spyre Therapeutics, Inc. · SEE REMARKS

King-Jones Heidy

Every open-market transaction filed under this name, Sep 1 to Sep 2.

Filings
5
0 buys · 5 sells
Bought
open market, at cost
Sold
$2.5M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 2SYRESpyre Therapeutics, Inc.See RemarksSell400$90.00$36K−1.1%
Sep 1SYRESpyre Therapeutics, Inc.See RemarksSell400$89.38$36K−0.4%
Sep 1SYRESpyre Therapeutics, Inc.See RemarksSell6,206$88.17$547K+0.9%
Sep 1SYRESpyre Therapeutics, Inc.See RemarksSell16,548$87.20$1.4M+2.0%
Sep 1SYRESpyre Therapeutics, Inc.See RemarksSell4,845$86.40$419K+3.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.